Portfolio map · Private equity · United States
Bain Capital Life Sciences portfolio map
41 startups Bain Capital Life Sciences has backed in rounds we track, since 2017, grouped by their main sector. Together they have raised $9.3B; Bain Capital Life Sciences led at least one round in 4 of them. The biggest sector is Biotech, with 32 companies.
Biotech
32
Kymera Therapeutics
ADC Therapeutics
Kailera Therapeutics
Nuvalent
New Amsterdam Pharma
AdvanCell
SpringWorks Therapeutics
Century Therapeutics
Solid Biosciences
Cardurion Pharmaceuticals
Nurix Therapeutics
Cabaletta Bio
Upstream Bio
Imperative Care
X4 Pharmaceuticals
Amylyx Pharmaceuticals
Kyverna Therapeutics
CereVasc
Alkeus Pharmaceuticals
Atsena Therapeutics
Replimune Group
Pharvaris- 2B2seventy bio
Merida Biosciences
+8 more
Funding by segment
- Biotech$7.8B32
- Pharma$1.2B6
- Healthtech$308M3
Where they are based
- United States33$7.0B
- Switzerland2$778M
- Netherlands1$453M
- Australia1$438M
- Germany1$55M
- United Kingdom1$442M
United States
Switzerland
Netherlands
Australia
Germany
United KingdomFounded
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M2
- $50M to $250M26
- $250M to $1B13
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
36 of 41 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States33
- Switzerland2
- Netherlands1
- Australia1
- Germany1
- United Kingdom1
Startups by country, 6 countries in all.
Segment by segment
Biotech
32 startups · $7.8B raised
- Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
- ADC TherapeuticsADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.Switzerland$646M
- Kailera TherapeuticsKailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.United States$600M
- NuvalentNuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.United States$500M
- New Amsterdam PharmaNew Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.Netherlands$453M
- AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
- SpringWorks TherapeuticsSpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.United States$400M
- Century TherapeuticsCentury Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.United States$385M
Pharma
6 startups · $1.2B raised
OMass TherapeuticsOMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule meUnited Kingdom$442M
Emalex BiosciencesEmalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.United States$270M- ABAiolos BioAiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.United States$245M
Timberlyne TherapeuticsTimberlyne Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, founded in 2024.United States$180M
Interius BioTherapeuticsInterius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.United States$73M
Xilio TherapeuticsXilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.United States$40M
Healthtech
3 startups · $308M raised
Kestra Medical Technologies, Inc.Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.United States$138M
Apreo HealthApreo Health is a clinical-stage medical device company based in Menlo Park, California, founded in 2021.United States$130M- R2River 2 RenalRiver 2 Renal is a developer of novel therapies intended to cure orphan diseases.-$40M
How this map is made. Every startup here has raised money in a round we track that names Bain Capital Life Sciences as an investor, the first in 2017. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Bain Capital Life Sciences?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.